This site uses cookies to ensure the best viewing experience for our readers.
FIMI Makes $25 Million Private Placement in Biomed Company Kamada

Brief

FIMI Makes $25 Million Private Placement in Biomed Company Kamada

Israel-based private equity fund FIMI became the largest shareholder in Nasdaq and Tel Aviv-listed Kamada in November

Tzally Greenberg | 10:44  22.01.2020
Israel-based private equity firm FIMI Opportunity Funds has agreed to make a $25 million private placement in Nasdaq and Tel Aviv-listed biomed company Kamada Ltd., the latter announced Tuesday. Kamada will issue FIMI a little over 4 million ordinary shares at $6 per share, an 8% discount on its closing price on Nasdaq Friday.

Following the placement, FIMI will own approximately 21% of Kamada’s outstanding ordinary shares. FIMI became Kamada’s largest shareholder in November when it paid $30 million for a 12% stake in the company.  
Kamada CEO Amir London. Photo: Nati Levi Kamada CEO Amir London. Photo: Nati Levi Kamada CEO Amir London. Photo: Nati Levi

Kamada, which develops protein-based pharmaceuticals, said it will use the proceeds to finance its growth and to execute strategic business opportunities.

share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS